What is Echopixel?
EchoPixel, Inc. is at the forefront of medical technology, developing a sophisticated software platform that empowers physicians with a digital twin of patients. Visualized as a 4D interactive hologram derived from standard medical images, this technology revolutionizes the understanding of complex 3D anatomical relationships. This innovation is particularly impactful for surgical planning and intra-operative guidance, addressing critical challenges in healthcare. The company's technology has achieved FDA 510k clearance and is being adopted by leading hospitals, especially within structural and congenital heart programs, marking a significant advancement in patient care.
How much funding has Echopixel raised?
Echopixel has raised a total of $19.7M across 6 funding rounds:
Unspecified
$1M
Angel/Seed
$2.4M
Unspecified
$1.8M
Private Equity
$6M
Series A
$8.5M
Debt
$150K
Unspecified (2012): $1M, investors not publicly disclosed
Angel/Seed (2013): $2.4M, investors not publicly disclosed
Unspecified (2016): $1.8M supported by AutoTech Ventures and Aurus Capital
Private Equity (2017): $6M featuring Aurus and 180 Degree Capital Corp
Series A (2017): $8.5M backed by Intel Capital, LAM Research, Aurus Capital, Binomial Ventures, 180 Degree Capital Corp, and Runa Capital
Debt (2020): $150K with participation from PPP
Key Investors in Echopixel
Intel Capital
Intel Capital, a division of Intel, invests in innovative startups targeting artificial intelligence, autonomous vehicles, datacenter, Cloud, 5G, and next-generation compute technologies, leveraging its extensive business development network.
Aurus Capital
Aurus Ventures is a venture investment firm focused on Spanish-speaking Latin America, investing in technology and life sciences companies with global vision and strong execution capabilities.
Binomial Ventures
Binomial Ventures is an investment firm based in Moscow that concentrates on fintech and cybersecurity companies, investing in early and medium-stage ventures across Europe and North America.
What's next for Echopixel?
With the recent major strategic investment and substantial overall capital secured, Echopixel is poised for significant expansion and technological advancement. The company's focus on precision health solutions, particularly its FDA-cleared digital twin technology, positions it for growth in the competitive medtech landscape. Future developments are likely to involve further integration into clinical workflows, expansion into new medical specialties beyond cardiology, and potential partnerships to scale its reach globally. The strategic backing suggests a trajectory towards broader market penetration and continued innovation in patient-specific medical visualization.
See full Echopixel company page
